Marijuana Stocks & Public Companies

Investment firm offers CA$1M seed money to Canadian marijuana entrepreneurs

A major investment company is putting 1 million Canadian dollars ($780,000) on the table for aspiring cannabis entrepreneurs in Canada. Canopy Rivers Corp.’s program is open to entrepreneurs looking to access Health Canada’s proposed new licenses for micro-cultivation, nurseries, industrial hemp, processing, analytical testing, retailers and other emerging segments. “This is a way to help […]

Read More

Colombian marijuana companies seek first listings on Canadian exchange

As interest in Latin America’s medical marijuana industry grows, a major stock exchange in Canada could soon see the first listings from companies with their core operations in Colombia. Khiron Life Sciences CEO Alvaro F. Torres told Marijuana Business Daily the company expects to complete the regulatory paperwork in time to start trading as early […]

Read More

What Canada’s top CEOs say about cannabis ‘commoditization’

While a shortage of marijuana is expected to precede any glut by a number of years, the potential for cannabis commoditization is already a consideration for many licensed cultivators in Canada. Greg Engel, CEO of New Brunswick-based Organigram, said commoditization, at least as it relates to cannabis, boils down to two things: Excess supply over […]

Read More

Chicago-based cannabis firm GTI plans to go public in Canada

Green Thumb Industries, a Chicago-based cannabis grower and dispensary operator, released its plans to go public in Canada’s booming marijuana market. The multistate company has signed a letter of intent to complete a reverse takeover of Vancouver, British Columbia-based Bayswater Uranium Corp., which has interests in properties across Canada and in Wyoming. The deal charts […]

Read More

Marijuana firm iAnthus lands $50 million investment

Multistate cannabis firm iAnthus secured a $50 million investment from Gotham Green Partners, a marijuana-focused private equity firm based in New York. The deal, announced Monday, is one of the largest investments by a single investor in a U.S.-based publicly traded cannabis firm, according to a news release. Net cash proceeds to the firm are […]

Read More

Four marijuana firms to form multinational company, continuing industry consolidation

Consolidation continued in the cannabis industry Tuesday, with four major marijuana businesses from the United States and Canada merging to launch a multinational company with combined revenue forecast to total more than $200 million next year.

Operating under the name TILT Holdings, the new companies will include the combined operations of Baker Technologies, Sea Hunter, Briteside and Santa Veritas Therapeutics, according to a news release.

Read More

Aurora Cannabis to acquire Canadian rival MedReleaf for CA$3.2B in industry’s biggest deal

Aurora Cannabis has agreed to acquire rival Canadian cannabis producer MedReleaf in a deal valued at $3.2 billion Canadian dollars ($2.5 billion) that would create the largest marijuana company in the world. The transaction, announced Monday, marks the largest deal inked in the cannabis sector to date, giving the combined company a footprint that will […]

Read More

Canopy seeks to become first marijuana producer traded on New York Stock Exchange

Canada’s market leader in medical marijuana has applied to trade its shares on the New York Stock Exchange, a move that would make it the first cannabis-producing company to list on the world’s largest stock market.

Smiths Falls, Ontario-based Canopy Growth said in a news release it expects its shares to begin trading on the NYSE “before the end of May” under the symbol CGC.

Read More

Kevin O’Leary of ‘Shark Tank’: Institutional investors want to wager on cannabis – just not yet

Big institutional investors are sitting on billions of dollars they’d like to pump into the marijuana industry, but that’s not likely to happen as long as cannabis remains illegal in the eyes of Uncle Sam, according to investment mogul Kevin O’Leary. “The amount of capital that wants to come into this space is unprecedented,” said […]

Read More

McLellan calls on Canadian Senate to avoid ‘undue partisanship’ to get around rec cannabis delay

The former chair of Canada’s federal task force on cannabis legalization is calling on senators to avoid “undue partisan activity” as the bill faces the potential of a delay over contentious amendments that are under consideration. The Senate has every right to consider the Cannabis Act rigorously, Anne McLellan told Marijuana Business Daily. “But I’m hoping that partisanship […]

Read More